Search

everythinglearnresearchcommunity

for

Search:↓

A woman's complete hair loss condition improved after recovering from COVID-19.

Activated PRP injections are effective in treating hair loss and improving hair density.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

Assessing CD8+ T cell levels before surgery may improve vitiligo treatment outcomes.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Non-drug therapies show promise for hair regrowth but need more research.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Platelet-rich plasma therapy is a safe and effective treatment for alopecia areata.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Araliadiol may promote hair growth like minoxidil without being toxic.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

DN106212, an extract from a plant, is better at promoting hair growth than other tested substances by affecting hair growth factors and follicle development.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Some treatments like pentoxifylline with topical corticosteroids might work for alopecia areata, but more research is needed to find the best one.